Biotech

Career and Jobs News

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 27.01.2022.

Biotechnology
Management
Autoimmunity
Influenza pandemic
Executive officer
Chemical industry

Career And Jobs

@CALifeSciences shared
On Jan 26, 2022
We're looking for a Marketing and Programs Manager to join our growing team! APPLY TODAY: https://t.co/61MXzijrSI https://t.co/N1P5XGby0o
Open
Manager, Marketing and Programs

Manager, Marketing and Programs

Job Title: Manager, Marketing and Programs Job Level: Manager Report to: Vice President, Marketing and Programs Location: South San Francisco, San Diego or Sacramento, CA Hours: Full-time; ...

@MALifeSciences shared
On Jan 25, 2022
RT @kennturner: At @MALifeSciences, we are in the jobs business. My team and I are working incredibly close with our stakeholders across MA to accelerate partnerships and collaborations and help crack the code on workforce and DE&I in the life sciences. https://t.co/SevMFiAVJa
Open
Ex-Massport executive tries to replicate agency’s success to diversify the biotech industry

Ex-Massport executive tries to replicate agency’s success to diversify the biotech industry

Bold Types is a weekly look at the movers and shakers in Boston's business scene.

@FierceBiotech shared
On Jan 26, 2022
Gilead continues support of cell therapy biotech Kyverna in $85 million series B fundraising https://t.co/vKQ3ehcBsj
Open
Gilead tags along again to support cell therapy biotech Kyverna in $85M fundraising

Gilead tags along again to support cell therapy biotech Kyverna in $85M fundraising

Gilead has tagged along on Kyverna Therapeutics’ journey as a startup since the beginning, and now the Big Pharma has helped stock up the cell therapy biotech in an $85 million financing ...

@biospace shared
On Jan 25, 2022
@BayerUS-backed biotech snags $80M series A for AI-powered cell therapies #celltherapy #biotech https://t.co/wr7NY7luG6
Open
Bayer-Backed Biotech Snags $80M Series A for AI-Powered Cell Therapies

Bayer-Backed Biotech Snags $80M Series A for AI-Powered Cell Therapies

Cellino is a closed loop cell therapy manufacturing company that aims to make stem cell-based regenerative therapies available to all eligible patients and researchers using cells in ...

@CALifeSciences shared
On Jan 20, 2022
The effects of the #supplychain shortages have been particularly hard on new startups. Here’s how @TurtleTree_ has shown resilience when facing initial difficulties sourcing lab consumables. https://t.co/KHSioXLJmh
Open
TurtleTree shows resilience when facing initial difficulties in sourcing lab consumables

TurtleTree shows resilience when facing initial difficulties in sourcing lab consumables

Earlier this year, TurtleTree opened its new lab in Woodland, California. TurtleTree is a Singapore-and-US-based biotech company that pioneers cell-based technology to create sustainable ...

@JohnCendpts shared
On Jan 25, 2022
Nasal sprays to stave off viruses days at a time? J&J’s newest biotech partner draws $140M for 'proactive' approach By @AmberTongPW https://t.co/cijpzf4KAI
Open
Nasal sprays to stave off viruses days at a time? J&J’s newest biotech partner draws $140M for 'proactive' approach

Nasal sprays to stave off viruses days at a time? J&J’s newest biotech partner draws $140M for 'proactive' approach

Vaccines. Antibodies. Antivirals. The Covid-19 pandemic has given the world a crash course on the key medical tools that can protect humans from viruses. But one startup believes there’s ...

@JohnCendpts shared
On Jan 26, 2022
Never a dull moment in this biz: Big Pharma R&D legend Paul Stoffels is trading his J&J title for the CEO role at one of the most deeply troubled biotechs in the industry https://t.co/4T6m69nIPo
Open
Big Pharma R&D legend Paul Stoffels is trading his J&J title for the CEO role at one of the most deeply troubled biotechs in the industry

Big Pharma R&D legend Paul Stoffels is trading his J&J title for the CEO role at one of the most deeply troubled biotechs in the industry

After 20 years working at the pinnacle of Big Pharma R&D, taking lead roles in J&J’s pipeline revamp and a quickly developed, one-shot Covid vaccine that is being sold around the world, it ...

@biospace shared
On Jan 21, 2022
BioSpace movers & shakers, Jan. 21 #medicalbusiness #biotech https://t.co/RZyGMsESiQ
Open
BioSpace Movers & Shakers, Jan. 21

BioSpace Movers & Shakers, Jan. 21

Biopharma and life sciences companies made numerous appointments this week to boards and executive teams. These Movers & Shakers will position the companies for future growth.